BioMoti is very pleased to announce that it is shortlisted in the Best Emerging Biotech category (Sponsored by James Cowper) alongside Atopix Therapeutics and Autifony Therapeutics for the OBN Awards 2013. The winners in each of ten categories will be announced at the OBN Annual Awards Dinner taking place on 1 October 2013 at the Ashmolean Museum of Art and Archaelogy, Oxford.

For further details, please visit the OBN website.